Pharmacokinetics of Sustained Serum Methotrexate Concentrations Secondary to Gastrointestinal Obstruction
Authors:
- 1 November 1981
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 70 (11) , 1194-1198
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Vincristine in the etiology of toxicity of high-dose methotrexate therapyCancer, 1980
- Evaluation of enzyme immunoassay, radioassay, and radioimmunoassay of serum methotrexate, as compared with liquid chromatography.Clinical Chemistry, 1980
- Pharmacokinetic monitoring of high-dose methotrexateCancer Chemotherapy and Pharmacology, 1979
- Effect of pleural effusion on high‐dose methotrexate kineticsClinical Pharmacology & Therapeutics, 1978
- Clinical Pharmacokinetics of Methotrexate1Clinical Pharmacokinetics, 1978
- Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate ToxicityNew England Journal of Medicine, 1977
- Pharmacokinetics of methotrexateClinical Pharmacology & Therapeutics, 1973
- Methotrexate PharmacokineticsJournal of Pharmaceutical Sciences, 1971
- The effect of organic acids on renal clearance of methotrexate in manClinical Pharmacology & Therapeutics, 1969